Call Us Toll Free: 1-800-388-9993

Johnson & Johnson (JNJ)

Available from the Temper Enrollment Service: Yes

Order DRIP Enrollment

Last Update On: 03/08/2010:

JNJ derives about half of its annual sales from foreign sources and 11.9% of 2008’s sales were devoted to R&D. The company has a strong balance sheet and net profit margins have averaged close to 18% over the last 10 years. Dividends have been increased annually for 47 straight years, with the latest increase bringing the payout to $1.96 per share, up from 1999’s payout of 55¢. Sales topped $61 billion in 2009, up from $27.5 billion in 1999. With $14.1 billion in cash assets, and a total debt load of only $11.6 billion, JNJ is in excellent financial shape. It has a 14% debt-to-capitalization ratio. Officers and directors own 5.3% and Berkshire owns 36.9 million of the 2.759 billion outstanding shares.

Industry: Health care & consumer products
Minimum Investment: $25.00
Maximum Investment: 50,000/year
Shares to qualify: 1
Recent Price: 57.83
Investing Fee: Co. pays fee
Fee for Dividends: Co. pays fee

Fee Information

For more detailed information on this company's DRIP, login or click here to subscribe.

You may also sign up for a free guest pass here to view this company's detailed information.

Information is based on an annual survey and updated when company changes become available.

FOR MORE
INFORMATION

And a free copy of The Moneypaper's direct investing brochure, please enter your contact information below.

* Required Field.